| NCT ID | NCT07232823 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pakistan Association of Cognitive Therapists |
| Condition | Obsessive-Compulsive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 166 participants |
| Start Date | 2024-10-20 |
| Primary Completion | 2025-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 166 participants in total. It began in 2024-10-20 with a primary completion date of 2025-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose aims to assess the efficacy of Brief Culturally Adapted Cognitive Behaviour Therapy (Ca-CBT) for the treatment of Obsessive Compulsive Disorder (OCD).
Eligibility Criteria
Inclusion Criteria: * Participants aged 18 years or above * Participants with at least an elementary level of reading and writing * Clinical diagnosis of Obsessive Compulsive Disorder, either alone or comorbid with depression or anxiety Exclusion Criteria: * Participants with excessive use of alcohol or drugs (using ICD-10 RDC for alcohol or drug abuse or dependence) * Those with significant cognitive impairment (for example, intellectual disability or dementia) * Or those with OCD comorbid active psychosis
Contact & Investigator
Farooq Naeem
PRINCIPAL INVESTIGATOR
Professional Association of Cognitive Therapy
Frequently Asked Questions
Who can join the NCT07232823 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obsessive-Compulsive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07232823 currently recruiting?
Yes, NCT07232823 is actively recruiting participants. Contact the research team at Muhammadaslam139@gmail.com for enrollment information.
Where is the NCT07232823 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07232823 clinical trial?
NCT07232823 is sponsored by Pakistan Association of Cognitive Therapists. The principal investigator is Farooq Naeem at Professional Association of Cognitive Therapy. The trial plans to enroll 166 participants.